From: Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease
Parameters | No event (n = 274) | Combined events (n = 17) | p-value |
---|---|---|---|
All patients (N = 291) | |||
Baseline hs-TnT | 12.88 (3.09, 294.20) | 16.92 (8.28, 124.90) | 0.038 |
Baseline Kynurenine | 5.23 (0.00, 11,731.00) | 1.97 (0.00, 32.84) | 0.036 |
Baseline IDO activity | 0.15 (0.00, 4.58) | 0.05 (0.00, 2.91) | 0.159 |
Insignificant CAD/SVD patients (n = 152) | No event (n = 146) | Combined events (n = 6) | |
---|---|---|---|
Baseline hs-TnT | 11.59 (3.09, 141.50) | 15.13 (12.89, 124.90) | 0.111 |
Baseline Kynurenine | 4.94 (0.00, 7892.33) | 0.38 (0.00, 4.45) | 0.017 |
Baseline IDO activity | 0.14 (0.00, 4.13) | 0.01 (0.00, 0.14) | 0.023 |
DVD/TVD patients (n = 139) | No event (n = 128) | Combined events (n = 11) | |
---|---|---|---|
Baseline hs-TnT | 15.05 (4.53, 294.20) | 17.13 (8.28, 61.03) | 0.290 |
Baseline Kynurenine | 5.70 (0.00, 11,731.00) | 4.37 (0.38, 32.84) | 0.264 |
Baseline IDO activity | 0.16 (0.00, 4.58) | 0.12 (0.01, 2.91) | 0.767 |